Abstract
Objective The aim of this study was to approach the relationship between the expression of human kallikrein 6 (hK6) in ovarian neoplasm and the clinicopathologic variables and prognosis for finding a new tumor marker for ovarian cancer.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have